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SUMMARY 
Epstein-Barr virus (EBV) from a human hybrid epithelial cell line (NPC-KT), 
derived from the fusion of human adenoidal cells and EBV genome-containing primary 
nasopharyngeal c rcinoma cells (NPC) has both transforming and early antigen (EA)- 
inducing abilities. EBV DNA from NPC-KT cells was partially digested with TaqI and 
ligated to the cloning vector pJB8 at the ClaI site. This cosmid library encompassed the 
whole genomic DNA of the virus except for several kb of the terminal fragments. The 
identification and location of each of the cloned DNA fragments have been defined by 
hybridization to blots prepared with B95-8 and NPC-KT virion DNA. Defective 
heterogeneous restriction enzyme fragments of the viral DNA were not identified in 
any of the cosmid clones nor detected inhybridizations to virion DNA, which indicates 
that a single virus population derived from the NPC tissue has both transforming and 
EA-inducing activities. 
INTRODUCTION 
The association of Epstein-Barr virus (EBV) with nasopharyngeal carcinoma (NPC) is 
consistent and universal. However, the study of the aetiological role of EBV in NPC has been 
impeded by the lack of any EBV-infected epithelial cell lines, the limited susceptibility of 
epithelial cells to EBV infection in vitro and the lack of detailed biological and molecular 
characterization f EBV derived from NPC (Raab-Traub et al., 1987; Sixbey et al., 1983). 
A hybrid epithelial cell line, NPC-KT, derived from the fusion of a human adenoidal 
epithelial cell line, Ad-Ah, and primary EBV-containing NPC, produces biologically active 
virus (Takimoto et al., 1984, 1985). The virus from NPC-KT cells has both transforming and 
early antigen (EA)-inducing abilities (Sato et al., 1986; Takimoto et al., 1985). Efficient 
induction of EA and viral DNA synthesis are properties of the non-transforming strain of EBV, 
HR-I, and have been linked to an unusual rearranged EBV DNA fragment found in the 
heterogeneous (het) defective DNA molecules present in this strain of EBV (Countryman &
Miller, 1985; Rabson et al., 1983). However, at least wo strains of EBV without defective viral 
populations can lso induce EA, but not viral DNA synthesis, upon infection of Raji cells (Lin & 
Raab-Traub, 1987). 
This study was undertaken tocharacterize the viral genome and to determine whether its dual 
activities could be ascribed to a single virus population. In addition, the virus found in NPC-KT 
provides an opportunity to characterize EBV of NPC origin in a strain never propagated in 
lymphocytes. Therefore we report here the molecular cloning and detailed mapping of EBV 
DNA from NPC-KT cells. 
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METHODS 
Viral DNA. NPC-KT cells were cultured in Dulbecco's modified Eagle's medium supplemented with 7~ 
foetal calf serum. The EBV producer lymphoid cell line, B95-8, was cultured in RPMI 1640 with 10~ foetal calf 
serum (Miller & Lipman, 1973). Virus was purified from NPC-KT by the method of Dolyniuk et al. (1976). Viral 
DNA was extracted with phenol and purified by equilibrium centrifugation i neutral CsCI. The DNA 
concentration was determined by optical density and comparison with known amounts of bacteriophage 2 DNA 
cleaved with HindlII, in agarose gels containing ethidium bromide. About 8 mg of viral DNA was obtained from 
3 1 of culture supernatant fluid. 
Recombinant DNA. The cosmid cloning method of Ish-Horowicz & Burke (1981) was applied with some 
modifications. Briefly, by digestion of the cloning vector, pJB8, with either PvulI or AvaI followed by 
dephosphorylation and ClaI digestion, left-hand and right-hand vector ends were produced which accepted 
inserted DNA fragments generated by partial digestion with TaqI. One mg of NPC-KT viral DNA was partially 
digested with 1 unit of TaqI at 65 °C for 1 h in a total volume of 100 ~tl. The extent of the reaction was monitored 
by electrophoresis. The DNA was precipitated with ethanol and redissolved in2 ml H20. Viral DNA was ligated 
with 0.5 p.g of the vector mixture in 5 ml for 24 h at 15 °C. In vitro packaging was done using strain BHB2688, and 
the packaged cosmids were used to infect Escherichia coli 490A, which is recA-. Single colonies grown on LB broth 
agar containing 100 mg/ml ampicillin were randomly picked and cultured in 5 ml L broth containing ampicillin. 
Subclones specific for the right- and left-terminal sequences were obtained from the cosmid clones 35 and 1. 
Digestion of clone 35 with BamHI resulted in the removal of part of the insert except for an 880 base fragment 
specific for the left end of the BamHI heterogeneous N fragment (Nhet). The plasmid was religated. A 1500 bp 
BamHI fragment specific for the left terminus was subcloned from cosmid clone I into a plasmid in the same way. 
Analysis of inserted DNA. The DNA from each recombinant bacterial clone was digested with EcoRI, HindlII, 
Sail or BamHI, electrophoresed in agarose gels, and the mobilities of each fragment of the EBV inserts were 
compared with total digests of B95-8 and NPC-KT EBV DNA. For the analysis of small fragments, 2.5mg of 
DNA was digested and separated on 4 ~ acrylamide gel using HaelII-digested colicin E 1 DNA fragments as size 
markers. Blot hybridization was employed to map the insert. Viral DNAs from B95-8 and NPC-KT digested to 
completion with each enzyme were separated on agarose gels and transferred tonitrocellulose filters (Southern, 
1975). Identical filter strips of each restriction endonuclease digest were made by slicing preparative Southern 
blots into strips 5 mm wide. DNA from the cosmid clones or from virus was labelled with [32p]dCTP by nick 
translation. Hybridization was carried out at 65 °C for 16 h in 50 mM-Tris-HC1 pH 7.5, containing 0.02~ 
polyvinylpyrrolidone, 0-02% bovine serum albumin, 0.02~ Ficoll, 10mM-EDTA, 1 M-NaCI, 0.1% SDS and 
20 mg/ml heat-denatured salmon sperm DNA. After hybridization, the nitrocellulose strips were washed with 
2 x SSC (1 x SSC is 150m~t-NaC1, 5 mM-trisodium citrate, pH 7.0) at room temperature and then with 
0.1 x SSC containing 0-1 ~ SDS at 50 °C. The filters were covered with Saran Wrap and exposed to X-ray film 
with an intensifying screen for autoradiography. The nomenclature and the sizes of each fragment of B95-8 DNA 
derived from the complete sequence of EBV DNA were utilized (Baer et al., 1984). For the fragments ofNPC-KT 
DNA, the nomenclature was assigned corresponding to the Mr values of the fragments (Fig. 1). 
RESULTS 
DNA from each clone was analysed by electrophoresis in agarose gels containing ethidium 
bromide after digestion with EcoRI, HindlII, SalI or BamHI and visualized with u.v. light (Fig. 
2a to d). Small DNA fragments were separated on 4~o acrylamide gels (Fig. 2e). These data 
enabled the accurate determinat ion of the Mr values of the BamHI, SalI, EcoRI and HindlII 
fragments within each cosmid clone. The faint unlabeUed bands in SalI digests represent partial 
digestion products. It should be noted that the fragments located at both ends of the insert DNA 
are ligated to vector DNA at the TaqI site and therefore have altered Mr values and are 
designated by arrowheads. The DNAs  from 10 clones were analysed further by blot 
hybridization using these DNAs  as probes against NPC-KT  or B95-8 viral DNA (Fig. 3 a to d). 
It was assumed that NPC-KT  DNA fragments that comigrated with B95-8 DNA and 
hybridized to the same cosmid DNA were identical or closely related and had the same map 
positions on the genome (Dambaugh et al., 1980). 
Comparison of these digestions indicated that the NPC-KT  viral DNA structure was similar 
to that of B95-8 viral DNA except for the deletion characteristic of the B95-8 strain in the EcoRI 
C fragment (Raab-Traub et al., 1980). The NPC-KT  EcoRI A fragment, identified by cosmid 
clones 1, 6, 9 and 20, was 6 kb shorter than that of B95-8, suggesting that it had fewer copies of 
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Fig. 2. Identification of the EcoRI (a), HindllI (b), SalI (c) and BamHI (d) fragments within the NPC- 
KT cosmid clones. The designated cosmid clones (number given above each lane) were digested with 
the required restriction enzyme and subjected toelectrophoresis in a0-6 ~ agarose gel. The Mf values of 
each of the fragments were determined by comparison with the HindlII fragments of phage 2. The 
arrowheads designate the terminal fragments which are ligated to v ctor DNA. The individual 
fragments are designated with the NPC-KT fragment letter determined after hybridization. Small 
fragments were separated on a 4~o acrylamide gel using HaelI-digested colicin E1 DNA as a molecular 
standard (e). Lanes 1 and 2, EcoRI-digested clones 20 and 5 respectively; lanes 3 to 7,HindlII-digested 
clones 20, 41, 5, 39 and 35 respectively; lane 8, SalI-digested clone 9; lanes 10to 12, BamHI-digested 
clones 41, 5 and 39 respectively. 
clone 35, corresponded to B95-8 EcoRI C but was 12 kb larger, indicating that virus from NPC- 
KT, like other prototype strains of EBV, does not have a deletion in the EcoRI C fragment 
(Raab-Traub et al., 1980). The NPC-KT C fragment, identified by clones 41, 5, 43, 47 and 39, 
was 5.4 kb smaller than the B95-8 EcoRI B fragment. However, these clones also hybridized to a 
novel EcoRI fragment, NPC-KT H2 (5.4 kb). NPC-KT H2 hybridized to the B95-8 B fragment 
(Fig. 4) and mapped between the NPC-KT K and C fragments. The size of B95-8 B was equal to 
the sum of NPC-KT C and H2, suggesting that the B95-8 B fragment was split into C and H2 
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Fig. 4. Mapping of NPC-KT unique fragments. The restriction enzyme fragments that were detected in 
the NPC-KT clones but which were not present in B95-8 were labelled with 32p and hybridized to 
duplicate blots of NPC-KT (odd-numbered lanes) or B95-8 (even-numbered lanes) virion DNA to 
identify which B95-8 fragment contained sequences homologous to the novel NPC-KT fragments. The 
restriction enzymes used to generate the novel fragments were: EcoRI (H2 fragment, lanes 1 and 2), 
HindlII (M3 fragment, lanes 3 and 4; N2 fragment, lanes 5 and 6; M2 fragment, lanes 7 and 8) and 
BamHI (I fragment, lanes 9 and 10; d2 fragment, lanes 11 and 12). They were used to digest the NPC- 
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Fig. 5. Identification of the terminal fragments of NPC-KT. To identify these, a probe specific for the 
left terminus (a) was hybridized to NPC-KT (lane 1) and B95-8 (lane 2) virion DNA digested with 
BamHl. A probe specific for the right terminus (b) was hybridized to NPC-KT (odd-numbered lanes) 
and B95-8 (even-numbered lanes) virion DNA digested with EcoRI (lanes 1 and 2), HindlII (lanes 3 and 
4), SalI (lanes 5 and 6) and BamHI (lanes 7 and 8). 
fragments in NPC-KT viral DNA.  The predominant EcoRI fragment of the NPC-KT viral 
DNA right terminus was 11.4 kb, about 1 kb shorter than the B95-8 right-terminal fragment 
Dhet, suggesting that the NPC-KT terminal fragment has fewer copies of the terminal repeat 
sequence, TR (Fig. 5). 
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On HindIII digestion, the size of the A fragment, like that of the EcoRI A, was smaller than 
that of B95-8 HindlII A by 6 kb, suggesting a loss of IR1 sequences (Fig. 3b). NPC-KT viral 
DNA M2 (1-4 kb), M3 (1.1 kb) and N2 (0.9 kb) were additional fragments not found in B95-8 
viral DNA digestions. The N2 and M2 fragments of NPC-KT hybridized to B95-8 L, the size of 
which was equal to the sum of NPC-KT N2 and M2, indicating an additional HindlII site in 
NPC-KT (Fig. 4). The NPC-KT M3 fragment hybridized to the C fragment of B95-8, and B95-8 
C was equal in size to the sum of the sizes of NPC-KT C and M3, suggesting that the B95-8 
HindlII C fragment was split into C and M3 fragments in NPC-KT DNA (Fig. 4). Two 
predominant right-terminal fragments of 4.4 and 4.9 kb were detected in NPC-KT DNA, 
whereas B95-8 DNA was more heterogeneous (Fig. 5). Cosmid clone 35, which hybridized to the 
HindlII D fragment of B95-8, contained three HindlII fragments, D 1, D2 and L, similar to other 
EBV strains (Bornkamm et al., 1980). 
On Sail digestion, the NPC-KT A fragment, which spans the IR1 repeats, was also 6 kb 
shorter than that of B95-8 (Fig. 3c). Hybridization of clones 20 and 41 identified unique 
fragments in NPC-KT, C (16.7 kb) and D2 (13-3 kb), which hybridized to the B95-8 C fragment 
(30.0 kb) indicating an additional Sail site in NPC-KT. In addition, NPC-KT had two SalI 
fragments, G2 and G3, identified by clone 35 which spanned the B95-8 deletion. 
In the BamHI digestions, the H fragment of NPC-KT was 0.4 kb longer than that of B95-8 
(Fig. 3 c). This fragment encompasses the small repeat sequence, IR2, and varies in size between 
strains of EBV. The presence of a single homogeneous BamHI H fragment suggests that a single 
virus strain is present. Similarly, the BamHI K fragment varies in size between strains of EBV 
and a single BamHI K fragment was detected in NPC-KT viral DNA. The number of IR1 
repeat sequences represented by BamHI W was estimated to be nine in NPC-KT, because the 
EcoRI, HindlII and SalI A fragments were 6 kb larger in B95-8, which has 11 copies of IR1. 
BamHI Y of NPC-KT was equal in size to that of B95-8, indicating that the sequences that 
encode EBNA 2 were not deleted in NPC-KT. The NPC-KT d2 fragment (810 bp) mapping 
between E and Z was unique; el (306 bp) and e2 (507 bp) mapping at this position in B95-8 
(Baer et al., 1984) were not detected, and only 0.8 kb d2 and e3 (520 bases) were included in
cosmid DNAs encompassing this region, indicating a loss of the BamHI site separating el and 
e2 (Fig. 4). NPC-KT I (5.5 kb) hybridized to B95-8 T (3-4 kb) and X (2.1 kb), indicating that the 
BamHI cleavage site between the T and X fragments of B95-8 DNA was lost in NPC-KT DNA 
(Fig. 4). 
To examine the right erminus of NPC-KT DNA, an 880 bp fragment from the rightmost 
BamHI site was cloned and hybridized to NPC-KT and B95-8 DNA digests (Fig. 5). This 
fragment identified the right-terminal fragments, EcoRI Dhet (11.4 kb) and SalI Dhet (15.7 kb) 
and predominant BamHI fragments of 4.2 and 4.7 kb and HindIII fragments of 4.9 and 4.4 kb. 
The B95-8 DNA right terminus was more heterogeneous. A 1500 bp fragment specific for the 
left terminus identified BamHI fragments of 4.7 and 5.2 kb in NPC-KT DNA. The B95-8 DNA 
left terminus was also more heterogeneous. The 1500 bp fragment did not hybridize to the NPC- 
KT DNA SalI het which is located at the left end of the genome to the left of the 1500 bp probe. 
DISCUSSION 
Despite its consistent presence in NPC, data on the molecular or biological properties of EBV 
in this epithelial malignancy are sparse. The NPC-KT virus represents a strain of EBV from 
NPC that has not been passaged in lymphocytes and therefore has not been selected for non- 
lytic properties that might result from such passage. The virus is unusual in that it has the 
capacity not only to transform lymphocytes, but also to superinfect latently infected cell lines 
and induce the synthesis of viral replicative antigens (Sato et al., 1986). Previous ubcloning of 
the NPC-KT cell line failed to separate the biological properties, suggesting that two viral 
strains were not responsible for the dual properties. 
In this study the genome of NPC-KT has been cloned and compared with the well 
characterized B95-8 strain of EBV. In summary, the NPC-KT EBV strain has fewer copies of 
the IR l sequence and fewer copies of the TR at each terminus. There are no deletions of unique 
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sequences, and the sequences that encode EBNA 2 have been retained. The sequences that 
encode the EBNA 2 gene of EBV are deleted in the non-transforming strains of EBV produced 
by the HR-1 and Daudi cell lines (Jones et al., 1984; King et al., 1982; Rabson et al., 1982). 
However, NPC-KT is similar to B95-8 and other transforming strains of EBV in that the 
sequences which encode EBNA 2 have been retained, indicated by non-deleted BamHI  H and Y 
fragments. This suggests that the loss of EBNA 2 sequences i  not a factor contributing to the 
ability of the HR-1 strain to superinfect. 
Although cloning of the viral DNA from a single specimen of unpassaged NPC revealed no 
striking differences when compared with the W91 strain of EBV, derived from a Burkitt 
lymphoma (Heller et al., 1981 ; Raab-Traub et al., 1980, 1987), multiple distinctive restriction 
enzyme polymorphisms do in fact characterize the NPC-KT genome. These restriction enzyme 
polymorphisms are homogeneous in all preparations and indicate that NPC-KT represents a 
single virus strain. In addition, restriction enzyme fragments of EBV that contain varying 
numbers of small repeat sequences, uch as the BamHI  H and K fragments, differ in Mr between 
EBV isolates; however, single BamHI  H and K fragments are detected in NPC-KT virus. These 
structural characteristics are distinctive for NPC-KT and indicate that a single virus strain 
possesses both of the key biological properties of EBV. 
The HR-1 strain of virus, which possesses the ability to superinfect Raji cells and activate 
DNA replication in latently infected cell lines, is also a single strain of virus. However, analysis 
of subclones of this strain indicated that the ability to induce EA synthesis efficiently appeared 
to be dependent on the presence of defective EBV genomes, although it is possible to induce EA 
without a defective subpopulation if the m.o.i, is high enough (Heston et al., 1982; Lin & Raab- 
Traub, 1987; Rabson et al., 1983). Gene transfer experiments have revealed that the replication 
activator function is encoded by a defective fragment in which sequences from the BamHI  Z 
fragment are linked to sequences from IR1 resulting in aberrant expression of the BZLF1 gene 
product (Countryman et al., 1987). However, unlike HR-1, defective fragments could not be 
detected inNPC-KT viral DNA (Fig. 3) even during long exposures of the strong hybridizations 
of the cosmids to virion DNA, and were not obtained in any of the recombinant cosmid DNA 
clones which span the NPC-KT genome. The superinfection process with NPC-KT virus has 
recently been characterized further (Sato et al., 1988). After superinfection both the endogenous 
and superinfecting genomes are amplified without evidence of the presence or production of 
defective DNAs. Defective genomic DNA is preferentially amplified after superinfection with 
HR-1 virus (Miller et al., 1985). 
The basis for the unusual property of NPC-KT to induce fficiently both EA and viral DNA 
synthesis as yet unknown because it cannot be attributed to rearranged fragments as in HR-1. 
Analysis of the DNA structure of the BamHI  Z fragment, which encodes the EBV replication 
activator protein, does not reveal any major structural differences in NPC-KT virion DNA or in 
DNA replicated after superinfection (Sato et al., 1988). However, NPC-KT virus is unique in 
that its ability to activate EA synthesis and viral replication is enhanced by treatment with 
DMSO (Sato et al., 1988). It is possible that small sequence changes in the promoter of the 
BamHI  Z activating function could result in enhanced expression after treatment with DMSO. 
Alternatively some other structural feature of the NPC-KT virus could contribute to its ability to 
replicate after superinfection. NPC-KT virus circularizes or forms concatemers very efficiently 
after superinfection, which could contribute to establishment of the superinfecting viral genome 
and promote viral expression (Sato et al., 1988). 
NPC-KT is the first virus strain obtained from NPC that has not been passaged in 
lymphocytes. Therefore it is possible that the superinfecting capacity of NPC-KT is 
characteristic of wild-type epithelial strains or any wild-type strain not selected by 
transformation f lymphocytes. This property could be responsible for the elevated serological 
titres to EA and other replicative antigens which are characteristic of patients with NPC. 
This work was supported by grants CA 19014 and CA 32979 from the National Cancer Institute. We also would 
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